Farouk Mohamed E. Abdel-Megeid
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Farouk Mohamed E. Abdel-Megeid has a total of 65 co-authors. Here are the top co-authors by number of shared publications:
- Mohamed Ibrahim Hegab
National Research Centre
12 shared publications - Aymn. E. Rashad
Photochemistry Department, Chemical Industries Research Institute, National Research Centre, 33 El Buhouth Street, P.O. Box 12622, Cairo, Egypt
8 shared publications - Ahmed Hussien Shamroukh
Photochemistry Department, Chemical Industries Research Institute, National Research Centre, 33 El Buhouth Street, P.O. Box 12622, Cairo, Egypt
4 shared publications Nasser A. Hassan
Photochemistry Dept., National Research Centre, Dokki, 12622 Cairo, Egypt
4 shared publications- Farouk A. Gad
Photochemistry Department , National Research Center , Cairo, Egypt
3 shared publications Mohamed A.-F. Elkaschef
National Research Centre, Dokki, Cairo (Egypt)
3 shared publications
Latest Publications
- 29 September 2026
- Published by Bentham Science Publishers Ltd. in Current Organic Chemistry
- Vol. 30, 1-16
A Comprehensive Review of Azolo[d]pyrimidines Derived from Pyrimidine with Potential Biological Applications: Part I - One-Nitrogen Azoles
This review highlights the pyrimidine ring as a highly versatile and valuable core scaffold for the construction of fused azolo[d]pyrimidine systems, particularly pyrrolo[d]pyrimidines containing a single nitrogen atom within the azole ring (part-1). Fusion of a pyrrole moiety with the pyrimidine nucleus gives rise to structurally diverse regioisomeric frameworks, namely pyrrolo[2,3-d]pyrimidines (9-deazaguanines), pyrrolo[ 3,2-d]pyrimidines (7-deazapurines), and pyrrolo[3,4-d]pyrimidines, each exhibiting distinct structural characteristics and diverse biological profiles. Collectively, pyrrolo[d]pyrimidines have shown promising biological activities, including anticancer, antimicrobial, and anti-inflammatory effects, underscoring their importance in drug discovery. This review provides a comprehensive overview of their regioisomeric classification, synthetic approaches, recent methodological advances, and emerging biological significance, emphasizing their role as important scaffolds for future medicinal chemistry and pharmaceutical development.
- 29 September 2026
- Published by Bentham Science Publishers Ltd. in Current Organic Chemistry
- Vol. 30, 1-16
A Comprehensive Review of Azolo[d]pyrimidines Derived from Pyrimidine with Potential Biological Applications: Part I - One-Nitrogen Azoles
This review highlights the pyrimidine ring as a highly versatile and valuable core scaffold for the construction of fused azolo[d]pyrimidine systems, particularly pyrrolo[d]pyrimidines containing a single nitrogen atom within the azole ring (part-1). Fusion of a pyrrole moiety with the pyrimidine nucleus gives rise to structurally diverse regioisomeric frameworks, namely pyrrolo[2,3-d]pyrimidines (9-deazaguanines), pyrrolo[ 3,2-d]pyrimidines (7-deazapurines), and pyrrolo[3,4-d]pyrimidines, each exhibiting distinct structural characteristics and diverse biological profiles. Collectively, pyrrolo[d]pyrimidines have shown promising biological activities, including anticancer, antimicrobial, and anti-inflammatory effects, underscoring their importance in drug discovery. This review provides a comprehensive overview of their regioisomeric classification, synthetic approaches, recent methodological advances, and emerging biological significance, emphasizing their role as important scaffolds for future medicinal chemistry and pharmaceutical development.
- Open Access
- 14 March 2022
- Published by MDPI AG in Pharmaceuticals
- Vol. 15 (3) , 351
In Vitro and In Vivo Antiviral Studies of New Heteroannulated 1,2,3-Triazole Glycosides Targeting the Neuraminidase of Influenza A Viruses
There is an urgent need to develop and synthesize new anti-influenza drugs with activity against different strains, resistance to mutations, and suitability for various populations. Herein, we tested in vitro and in vivo the antiviral activity of new 1,2,3-triazole glycosides incorporating benzimidazole, benzooxazole, or benzotriazole cores synthesized by using a click approach. The Cu-catalyzation strategy consisted of 1,3-dipolar cycloaddition of the azidoalkyl derivative of the respective heterocyclic and different glycosyl acetylenes with five or six carbon sugar moieties. The antiviral activity of the synthesized glycosides against wild-type and neuraminidase inhibitor resistant strains of the avian influenza H5N1 and human influenza H1N1 viruses was high in vitro and in mice. Structure–activity relationship studies showed that varying the glycosyl moiety in the synthesized glycosides enhanced antiviral activity. The compound (2R,3R,4S,5R)-2-((1-(Benzo[d]thiazol-2-ylmethyl)-1H-1,2,3-triazol-4-yl)methoxy)tetrahydro-2H-pyran-3,4,5-triyl triacetate (Compound 9c) had a 50% inhibitory concentration (IC50) = 2.280 µM and a ligand lipophilic efficiency (LLE) of 6.84. The compound (2R,3R,4S,5R)-2-((1-((1H-Benzo[d]imidazol-2-yl)methyl)-1H-1,2,3-triazol-4-yl)methoxy)tetrahydro-2H-pyran-3,4,5-triyl triacetate had IC50 = 2.75 µM and LLE = 7.3 after docking analysis with the H5N1 virus neuraminidase. Compound 9c achieved full protection from H1N1 infection and 80% protection from H5N1 in addition to a high binding energy with neuraminidase and was safe in vitro and in vivo. This compound is suitable for further clinical studies as a new neuraminidase inhibitor.
- 14 March 2022
- Published by MDPI AG in Pharmaceuticals
- Vol. 15 (3) , 351
Open AccessIn Vitro and In Vivo Antiviral Studies of New Heteroannulated 1,2,3-Triazole Glycosides Targeting the Neuraminidase of Influenza A Viruses
There is an urgent need to develop and synthesize new anti-influenza drugs with activity against different strains, resistance to mutations, and suitability for various populations. Herein, we tested in vitro and in vivo the antiviral activity of new 1,2,3-triazole glycosides incorporating benzimidazole, benzooxazole, or benzotriazole cores synthesized by using a click approach. The Cu-catalyzation strategy consisted of 1,3-dipolar cycloaddition of the azidoalkyl derivative of the respective heterocyclic and different glycosyl acetylenes with five or six carbon sugar moieties. The antiviral activity of the synthesized glycosides against wild-type and neuraminidase inhibitor resistant strains of the avian influenza H5N1 and human influenza H1N1 viruses was high in vitro and in mice. Structure–activity relationship studies showed that varying the glycosyl moiety in the synthesized glycosides enhanced antiviral activity. The compound (2R,3R,4S,5R)-2-((1-(Benzo[d]thiazol-2-ylmethyl)-1H-1,2,3-triazol-4-yl)methoxy)tetrahydro-2H-pyran-3,4,5-triyl triacetate (Compound 9c) had a 50% inhibitory concentration (IC50) = 2.280 µM and a ligand lipophilic efficiency (LLE) of 6.84. The compound (2R,3R,4S,5R)-2-((1-((1H-Benzo[d]imidazol-2-yl)methyl)-1H-1,2,3-triazol-4-yl)methoxy)tetrahydro-2H-pyran-3,4,5-triyl triacetate had IC50 = 2.75 µM and LLE = 7.3 after docking analysis with the H5N1 virus neuraminidase. Compound 9c achieved full protection from H1N1 infection and 80% protection from H5N1 in addition to a high binding energy with neuraminidase and was safe in vitro and in vivo. This compound is suitable for further clinical studies as a new neuraminidase inhibitor.
- 2 November 2015
- Published by Taylor & Francis in Phosphorus, Sulfur, and Silicon and the Related Elements
- Vol. 190 (11) , 1901-1911
Synthesis and Characterization of New 3″,5″-DIARYL-3″H-Dispiropyran/Thiopyran[4,2′-Chroman-3′,2″-[1,3,4-Thiadiazol]-4′-One Derivatives and Related Compounds as Anticancer and Antiviral Agents
A series of 3″,5″-diaryl-3″H-dispiropyran/thiopyran[4,2′-chroman-3′,2″-[1,3,4-thiadiazol]-4′-ones 5a-n were synthesized from the reaction of trispiro[tetrahydropyran(tetrahydrothiopyran)-4,5′-2H-chromeno-[3,4-e][1,3,4]oxadithiin-2′,3″-chroman-2″4′″-tetrahydropyran-(tetrahydrothiopyran)]-4″-ones 3a,b with nitrilimines (generated in situ via triethylamine dehydrohalogenation of the corresponding hydrazonoyl chlorides). A single crystal diffraction of compound 5a adds support for the established structure. The results of the anticancer evaluation against human breast adenocarcinoma MCF-7 cell line through inhibiting of human tyrosine kinase showed that most of the tested compounds possess antiproliferative activity as potent to moderate growth inhibitory activity, especially compounds 3b, 5a, 5c, 5e, 5g, and 5k. Also, the prepared compounds were tested against rotavirus Wa strain and adenovirus type 7 and the results showed that two compounds (5e,n) were active.
- 2 November 2015
- Published by Taylor & Francis in Phosphorus, Sulfur, and Silicon and the Related Elements
- Vol. 190 (11) , 1901-1911
Synthesis and Characterization of New 3″,5″-DIARYL-3″H-Dispiropyran/Thiopyran[4,2′-Chroman-3′,2″-[1,3,4-Thiadiazol]-4′-One Derivatives and Related Compounds as Anticancer and Antiviral Agents
A series of 3″,5″-diaryl-3″H-dispiropyran/thiopyran[4,2′-chroman-3′,2″-[1,3,4-thiadiazol]-4′-ones 5a-n were synthesized from the reaction of trispiro[tetrahydropyran(tetrahydrothiopyran)-4,5′-2H-chromeno-[3,4-e][1,3,4]oxadithiin-2′,3″-chroman-2″4′″-tetrahydropyran-(tetrahydrothiopyran)]-4″-ones 3a,b with nitrilimines (generated in situ via triethylamine dehydrohalogenation of the corresponding hydrazonoyl chlorides). A single crystal diffraction of compound 5a adds support for the established structure. The results of the anticancer evaluation against human breast adenocarcinoma MCF-7 cell line through inhibiting of human tyrosine kinase showed that most of the tested compounds possess antiproliferative activity as potent to moderate growth inhibitory activity, especially compounds 3b, 5a, 5c, 5e, 5g, and 5k. Also, the prepared compounds were tested against rotavirus Wa strain and adenovirus type 7 and the results showed that two compounds (5e,n) were active.
- 24 October 2013
- Published by Springer Nature in Medicinal Chemistry Research
- Vol. 23 (5) , 2515-2527
Pharmacological evaluation of some novel synthesized compounds derived from spiro(cyclohexane-1,2′-thiazolidines)
- 24 October 2013
- Published by Springer Nature in Medicinal Chemistry Research
- Vol. 23 (5) , 2515-2527
Pharmacological evaluation of some novel synthesized compounds derived from spiro(cyclohexane-1,2′-thiazolidines)
- 24 June 2013
- Published by Wiley in Journal of Heterocyclic Chemistry
- Vol. 50 (4) , 758-765
Some New Pyrazole and Pyrazolopyrimidines: Synthesis and Antimicrobial Evaluation
- 24 June 2013
- Published by Wiley in Journal of Heterocyclic Chemistry
- Vol. 50 (4) , 758-765
Some New Pyrazole and Pyrazolopyrimidines: Synthesis and Antimicrobial Evaluation
- 28 December 2009
- Published by Taylor & Francis in Phosphorus, Sulfur, and Silicon and the Related Elements
- Vol. 185 (1) , 74-83
Synthesis and Antitumor Evaluation of Some Newly Synthesized Pyrazolopyrimidine and Pyrazolotriazolopyrimidine Derivatives
A series of novel pyrazolo[3,4-d]pyrimidine 2b, 3, 5b, pyrazolotetrazolopyrimidine 4, and pyrazolotriazolopyrimidine derivatives 6a,b–10a,b have been synthesized and characterized by elemental analysis and spectroscopic data. Furthermore, the cytotoxicity and in vivo antitumor evaluation of some prepared compounds have been assessed, and derivatives 1a and 6b revealed promising activity in comparison to that of Cisplatin. Supplemental materials are available for this article. Go to the publisher's online edition of Phosphorus, Sulfur, and Silicon and the Related Elements to view the free supplemental file.
- 28 December 2009
- Published by Taylor & Francis in Phosphorus, Sulfur, and Silicon and the Related Elements
- Vol. 185 (1) , 74-83
Synthesis and Antitumor Evaluation of Some Newly Synthesized Pyrazolopyrimidine and Pyrazolotriazolopyrimidine Derivatives
A series of novel pyrazolo[3,4-d]pyrimidine 2b, 3, 5b, pyrazolotetrazolopyrimidine 4, and pyrazolotriazolopyrimidine derivatives 6a,b–10a,b have been synthesized and characterized by elemental analysis and spectroscopic data. Furthermore, the cytotoxicity and in vivo antitumor evaluation of some prepared compounds have been assessed, and derivatives 1a and 6b revealed promising activity in comparison to that of Cisplatin. Supplemental materials are available for this article. Go to the publisher's online edition of Phosphorus, Sulfur, and Silicon and the Related Elements to view the free supplemental file.
- 1 August 2009
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 44 (8) , 3285-3292
Synthesis and anti-HSV-1 evaluation of some pyrazoles and fused pyrazolopyrimidines
- 1 August 2009
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 44 (8) , 3285-3292
Synthesis and anti-HSV-1 evaluation of some pyrazoles and fused pyrazolopyrimidines
- Open Access
- 1 September 2008
- Published by Walter de Gruyter GmbH in Zeitschrift für Naturforschung B
- Vol. 63 (9) , 1117-1126
Three-component Reaction of Cycloheptanone, 6-Amino-1,3-Dimethyluracil and Aromatic Aldehydes; X-Ray Structure, and Anti-inflammatory Evaluation of the Products
1,3-Dimethyl-5-aryl-1,6,7,8,9,10-hexahydrocyclohepta[5,6]pyrido[2,3-d]pyrimidine-2,4-diones 4a, b (the linear regioisomers) and the Schiff bases, 6-N-benzylidenamino-1,3-dimethyluracil derivatives 5a, b, were isolated from a three-component reaction of cycloheptanone, 6-amino-1,3- dimethyluracil, and 4-chloro- or 4-bromobenzaldehyde. Surprisingly, 1,3-dimethyl-10-aryl-1,5,6,7, 8,9-hexahydrocyclohepta[4,5]pyrido-[2,3-d]pyrimidine-2,4-diones 6f, g (the angular regioisomers which are described for the first time in the literature under the given reaction conditions) and the Schiff bases, 6-N-benzylidenamino-1,3-dimethyluracil derivatives 5f, g, were isolated and characterized from the reaction with 4-methoxybenzaldehyde and 4-cyanobenzaldehyde. However, the three-component reaction of 6-amino-1,3-dimethyluracil, cycloheptanone, and 2-methoxybenzaldehyde afforded 1,3-dimethylbenzo[4,5]pyrido[3,2-d]pyrimidine-3,4-dione (7). Single crystal X-ray diffraction and 13C NMR studies of 4a and 6f provided support for the established structures. Some of the new products were tested for antiinflammatory activity comparable to indomethacin.
- 1 September 2008
- Published by Walter de Gruyter GmbH in Zeitschrift für Naturforschung B
- Vol. 63 (9) , 1117-1126
Open AccessThree-component Reaction of Cycloheptanone, 6-Amino-1,3-Dimethyluracil and Aromatic Aldehydes; X-Ray Structure, and Anti-inflammatory Evaluation of the Products
1,3-Dimethyl-5-aryl-1,6,7,8,9,10-hexahydrocyclohepta[5,6]pyrido[2,3-d]pyrimidine-2,4-diones 4a, b (the linear regioisomers) and the Schiff bases, 6-N-benzylidenamino-1,3-dimethyluracil derivatives 5a, b, were isolated from a three-component reaction of cycloheptanone, 6-amino-1,3- dimethyluracil, and 4-chloro- or 4-bromobenzaldehyde. Surprisingly, 1,3-dimethyl-10-aryl-1,5,6,7, 8,9-hexahydrocyclohepta[4,5]pyrido-[2,3-d]pyrimidine-2,4-diones 6f, g (the angular regioisomers which are described for the first time in the literature under the given reaction conditions) and the Schiff bases, 6-N-benzylidenamino-1,3-dimethyluracil derivatives 5f, g, were isolated and characterized from the reaction with 4-methoxybenzaldehyde and 4-cyanobenzaldehyde. However, the three-component reaction of 6-amino-1,3-dimethyluracil, cycloheptanone, and 2-methoxybenzaldehyde afforded 1,3-dimethylbenzo[4,5]pyrido[3,2-d]pyrimidine-3,4-dione (7). Single crystal X-ray diffraction and 13C NMR studies of 4a and 6f provided support for the established structures. Some of the new products were tested for antiinflammatory activity comparable to indomethacin.
- 1 August 2008
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 16 (15) , 7102-7106
Synthesis and antiviral evaluation of some new pyrazole and fused pyrazolopyrimidine derivatives
- 1 August 2008
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 16 (15) , 7102-7106
Synthesis and antiviral evaluation of some new pyrazole and fused pyrazolopyrimidine derivatives